Does RAMIPRIL Cause Exostosis? 296 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 296 reports of Exostosis have been filed in association with RAMIPRIL (Ramipril). This represents 0.9% of all adverse event reports for RAMIPRIL.
296
Reports of Exostosis with RAMIPRIL
0.9%
of all RAMIPRIL reports
247
Deaths
282
Hospitalizations
How Dangerous Is Exostosis From RAMIPRIL?
Of the 296 reports, 247 (83.4%) resulted in death, 282 (95.3%) required hospitalization, and 241 (81.4%) were considered life-threatening.
Is Exostosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 296 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Exostosis?
ADALIMUMAB (2,008)
METHOTREXATE (968)
ETANERCEPT (918)
ABATACEPT (775)
TOCILIZUMAB (768)
LEFLUNOMIDE (743)
SULFASALAZINE (712)
DICLOFENAC (702)
TOFACITINIB (702)
CERTOLIZUMAB PEGOL (695)
Which RAMIPRIL Alternatives Have Lower Exostosis Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE